GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » Gross Margin %

Sysmex (TSE:6869) Gross Margin % : 53.38% (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Sysmex Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Sysmex's Gross Profit for the three months ended in Dec. 2023 was 円60,759 Mil. Sysmex's Revenue for the three months ended in Dec. 2023 was 円113,826 Mil. Therefore, Sysmex's Gross Margin % for the quarter that ended in Dec. 2023 was 53.38%.

Warning Sign:

Sysmex Corp gross margin has been in long-term decline. The average rate of decline per year is -1.5%.


The historical rank and industry rank for Sysmex's Gross Margin % or its related term are showing as below:

TSE:6869' s Gross Margin % Range Over the Past 10 Years
Min: 50.58   Med: 55.72   Max: 62.1
Current: 53.16


During the past 13 years, the highest Gross Margin % of Sysmex was 62.10%. The lowest was 50.58%. And the median was 55.72%.

TSE:6869's Gross Margin % is ranked worse than
50.44% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 53.37 vs TSE:6869: 53.16

Sysmex had a gross margin of 53.38% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Sysmex was -1.50% per year.


Sysmex Gross Margin % Historical Data

The historical data trend for Sysmex's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Gross Margin % Chart

Sysmex Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.06 52.92 50.58 52.39 52.64

Sysmex Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.79 54.78 52.87 51.65 53.38

Competitive Comparison of Sysmex's Gross Margin %

For the Medical Instruments & Supplies subindustry, Sysmex's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Sysmex's Gross Margin % falls into.



Sysmex Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Sysmex's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=216082 / 410502
=(Revenue - Cost of Goods Sold) / Revenue
=(410502 - 194420) / 410502
=52.64 %

Sysmex's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=60759 / 113826
=(Revenue - Cost of Goods Sold) / Revenue
=(113826 - 53067) / 113826
=53.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Sysmex  (TSE:6869) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Sysmex had a gross margin of 53.38% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Sysmex Gross Margin % Related Terms

Thank you for viewing the detailed overview of Sysmex's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex (TSE:6869) Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (TSE:6869) Headlines

No Headlines